Propel Bio Management

Propel Bio Management as of June 30, 2025

Portfolio Holdings for Propel Bio Management

Propel Bio Management holds 16 positions in its portfolio as reported in the June 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Plains Gp Holdings Lp-cl Comm (PAGP) 30.0 $25M 1.3M 19.43
Achieve Life Sciences Comm (ACHV) 16.9 $14M 6.2M 2.26
Akero Therapeutics Comm (AKRO) 14.8 $12M 229k 53.36
Phathom Pharmaceuticals I Comm (PHAT) 10.7 $8.9M 923k 9.59
Abeona Therapeutics Comm (ABEO) 6.7 $5.5M 974k 5.68
Applied Therapeutics Comm (APLT) 4.3 $3.5M 11M 0.31
Milestone Pharmaceuticals Comm (MIST) 4.2 $3.5M 1.8M 1.94
Delcath Systems Comm (DCTH) 3.7 $3.1M 226k 13.60
Tscan Therapeutics Comm (TCRX) 3.7 $3.0M 2.1M 1.45
Zevra Therapeutics Comm (ZVRA) 2.5 $2.0M 232k 8.81
Capricor Therapeutics Comm (CAPR) 0.8 $695k 70k 9.93
Maat Pharma Saca Comm (MATPF) 0.5 $452k 94k 4.80
Athira Pharma Comm (ATHA) 0.5 $451k 1.5M 0.30
Eiger Biopharmaceuticals Comm 0.5 $423k 146k 2.89
WTS - Achieve Life Sci Comm 0.0 $14k 3.7M 0.00
Chinook Therapeutics Comm 0.0 $2.5k 79k 0.03